Pharmafile Logo
Pharmafocus logo
Advanced Search

ranibizumab

Showing 3 posts of 3 posts found.

Lucentis image

Novartis accused of Lucentis ‘campaign’ against Avastin

April 2, 2015
Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD

Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

News
Roche image

FDA clears Roche eye drug

February 9, 2015
Sales and Marketing AMD, DME, FDA, Lucentis, Retina, Roche, eyes, ranibizumab

The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …

News

Novartis’ Lucentis recommended for wider EU licence

October 25, 2010
Sales and Marketing CHMP, Genentech, Lucentis, Novartis, diabetic macular edema, ranibizumab

Novartis’ Lucentis has been recommended for approval in Europe to treat people suffering from vison loss due to diabetes. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025